Acceleron Pharma reported $59.48M in Current Liabilities for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acceleron Pharma XLRN:US $ 59.48M 9.66M
Akebia Therapeutics AKBA:US $ 165.6M 7.08M
Alexion Pharmaceuticals ALXN:US $ 1426.2M 198.5M
Amgen AMGN:US $ 14585M 1716M
Arena Pharmaceuticals ARNA:US $ 64.84M 17.33M
Bayer BAYN:GR € 27926M 1006M
Biomarin Pharmaceutical BMRN:US $ 443.34M 13.31M
Bluebird Bio BLUE:US $ 247.76M 41.45M
Clovis Oncology CLVS:US $ 173.88M 0.64M
Dicerna Pharmaceuticals DRNA:US $ 207.65M 25.5M
Eli Lilly And LLY:US $ 15093.2M 3379M
Exelixis EXEL:US $ 255.33M 41.99M
Gilead Sciences GILD:US $ 10214M 509M
GlaxoSmithKline GSK:LN 21387M 1112M
Johnson & Johnson JNJ:US $ 38721M 2211M
Karyopharm Therapeutics KPTI:US $ 58.12M 3.88M
Mirati Therapeutics MRTX:US $ 180.87M 103.76M
Neurocrine Biosciences NBIX:US $ 212.9M 22.9M
Novartis NOVN:VX SF 29633M 527M
Ptc Therapeutics PTCT:US $ 290.96M 40.01M
Puma Biotechnology PBYI:US $ 137.9M 2.51M
Regeneron Pharmaceuticals REGN:US $ 3732.4M 514.6M
Rigel Pharmaceuticals RIGL:US $ 59.54M 7.52M
Sangamo Biosciences SGMO:US $ 136.94M 4.1M
Ultragenyx Pharmaceutical RARE:US $ 127.07M 0.02M
United Therapeutics UTHR:US $ 311.4M 9M
Vertex Pharmaceuticals VRTX:US $ 1836.45M 107.6M